SAGE

Cancer Control Template

Write in a clean editor, then format for Cancer Control in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Cancer Control format

Cancer Control is a peer-reviewed journal published by SAGE, covering Global Cancer Incidence and Screening, Cancer survivorship and care, Cervical Cancer and HPV Research.

PublisherSAGE
Reference styleAuthor–year (Harvard)
Author–year — (Smith, 2023) in the text
Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Cancer Control, 12(3), pp. 45–58.

Formats any DOI in Cancer Control style. No sign-up.

Publishes research inGlobal Cancer Incidence and Screening Cancer survivorship and care Cervical Cancer and HPV Research Lung Cancer Treatments and Mutations Breast Cancer Treatment Studies
ISSN1073-2748
Citation impact (2-yr)2.74
h-index97
i10-index1,156
Total citations54,039
Article processing charge$2,200
Open accessYes
Top institutions publishing hereMoffitt Cancer Center
Journal websiteus.sagepub.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Cancer Control per year

56
2014
83
2015
68
2016
52
2017
40
2018
65
2019
124
2020
143
2021
178
2022
139
2023
218
2024
245
2025

Citation impact of Cancer Control by publication year

2.4K
2014
1.7K
2015
1.8K
2016
2.1K
2017
1.9K
2018
1.6K
2019
2.1K
2020
2.4K
2021
2.2K
2022
1.2K
2023
1.1K
2024
455
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Cancer Control

Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein

Hilary Thomas, Helen M. Coley · 1 Mar 2003

BACKGROUND: Multidrug resistance (MDR) is a significant obstacle to providing effective chemotherapy to many patients. Multifactorial in etiology, classic MDR is associated with the overexpression of P-glycoprotein (P-gp), resulting in increased efflux of chemotherapy from cancer cells. Inhibiting P-gp as a method to reverse MDR in cancer patients has been studied extensively, but the results…

Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Nader N. Massarweh, Hashem B. El‐Serag · 1 Sep 2017

Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) are the most frequently occurring types of primary liver cancer and together are among the most common incident cancers worldwide. There are a number of modifiable and nonmodifiable HCC and ICC risk factors that have been reported. A review of the existing literature the epidemiology and risk factors…

Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients with Cancer

Lauren M. Hamel, Louis A. Penner, Terrance L. Albrecht et al. · 1 Oct 2016

BACKGROUND: Clinical trials that study cancer are essential for testing the safety and effectiveness of promising treatments, but most people with cancer never enroll in a clinical trial - a challenge exemplified in racial and ethnic minorities. Underenrollment of racial and ethnic minorities reduces the generalizability of research findings and represents a disparity in access…

Liver Resection and Surgical Strategies for Management of Primary Liver Cancer

Sonia T. Orcutt, Daniel A. Anaya · 1 Jan 2018

Primary liver cancer-including hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC)-incidence is increasing and is an important source of cancer-related mortality worldwide. Management of these cancers, even when localized, is challenging due to the association with underlying liver disease and the complex anatomy of the liver. Although for ICC, surgical resection provides the only potential cure,…

Solitary Fibrous Tumor of the Pleura

Lary A. Robinson · 1 Oct 2006

BACKGROUND: The solitary fibrous tumor of the pleura (SFTP) is a rare primary tumor arising from mesenchymal cells in the areolar tissue subjacent to the mesothelial-lined pleura. Only about 800 cases have been reported in the medical literature. The tumor appears to be unrelated to malignant pleural mesothelioma, the most common primary tumor of the…

Cancer Control template — frequently asked questions

How do I write a paper in the Cancer Control format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Cancer Control template. When you export, DocuGuru compiles the paper into the official SAGE format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Cancer Control use?
Cancer Control uses Author–year (Harvard) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Cancer Control, 12(3), pp. 45–58.
Do I need to know LaTeX to submit to Cancer Control?
No. DocuGuru generates the sagej LaTeX class and compiles the PDF for you in the background, so you get a SAGE-ready Cancer Control document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Cancer Control template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Cancer Control format with correct headings, figures, tables, and author–year citations.
Who publishes Cancer Control?
Cancer Control is a multidisciplinary journal published by SAGE. DocuGuru's Cancer Control template matches SAGE's official submission format.
Can I export a submission-ready Cancer Control PDF?
Yes — DocuGuru produces a PDF built with the official Cancer Control template (the sagej class) that is ready to submit to SAGE, together with the matching LaTeX source files.
How much does the Cancer Control template cost?
You can start writing in the Cancer Control template for free. Exporting the final submission-ready Cancer Control PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Cancer Control template